CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $53,000 | +43.2% | 18,700 | +86.9% | 0.01% | +50.0% |
| Q4 2018 | $37,000 | +236.4% | 10,006 | +257.4% | 0.00% | +300.0% |
| Q3 2018 | $11,000 | -56.0% | 2,800 | -59.2% | 0.00% | -50.0% |
| Q2 2018 | $25,000 | +8.7% | 6,860 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $23,000 | -47.7% | 6,460 | -77.5% | 0.00% | 0.0% |
| Q4 2017 | $44,000 | +7.3% | 28,660 | -3.9% | 0.00% | +100.0% |
| Q3 2017 | $41,000 | -77.5% | 29,833 | -76.2% | 0.00% | -85.7% |
| Q2 2017 | $182,000 | -2.2% | 125,501 | +11.5% | 0.01% | 0.0% |
| Q1 2017 | $186,000 | +19.2% | 112,590 | -7.0% | 0.01% | +16.7% |
| Q4 2016 | $156,000 | +2500.0% | 121,122 | +1443.3% | 0.01% | – |
| Q3 2016 | $6,000 | -90.2% | 7,848 | -78.4% | 0.00% | -100.0% |
| Q2 2016 | $61,000 | -12.9% | 36,383 | -9.1% | 0.00% | -25.0% |
| Q1 2016 | $70,000 | -30.0% | 40,013 | -7.6% | 0.00% | -33.3% |
| Q4 2015 | $100,000 | – | 43,291 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|